Zur Startseite
Yanti Khusmiran
20
Jahre der Erfahrung

Yanti Khusmiran

  • Spezialisierung: Ästhetischer Arzt
  • 20 Jahre der Erfahrung
  • Arbeitsplatz: Mexiko, Cancún, Cellular Hope Institute
    • Director of the ISSCA Asia Chapter at Cellular Institute and a stem cell & aesthetic medicine pioneer.
    • Built Indonesia’s stem cell and aesthetic clinic network with 6+ branches across Surabaya, Jakarta, Bandung, and Bali.
    • Launched Natural Killer (NK) Cell therapy in Indonesia in 2023 at international GSCG/ISSCA-certified standards.
    • GSCG/ISSCA-certified training center in Jakarta that educates physicians on stem cell protocols, NK Cell therapy, and regenerative medicine standards.
    Yanti Khusmiran is a specialist at Cellular Institute and the Director of the ISSCA Asia Chapter. She has spent over two decades building Indonesia’s stem cell and aesthetic clinic network with 6+ branches, and she launched Natural Killer (NK) Cell therapy in Indonesia in 2023. Her Jakarta clinic is described as a GSCG/ISSCA-certified training center for physicians in stem cell protocols and NK Cell therapy standards.

Dienstleistungen des Arztes

Wie läuft es für Sie mit uns?

1 von 3
Die Informationen über diesen Arzt sind vollständig und klar
1
2
3
4
5
Stimme nicht zu
Stimme stark zu

Qualifikationen

Yanti Khusmiran is a specialist at Cellular Institute, where she serves as Director of the ISSCA Asia Chapter and an advisory-board figure for immunology and regenerative medicine. Her profile describes over two decades of pioneering regenerative and aesthetic medicine across Asia, paired with leadership in clinical education. She is credited with building Indonesia’s stem cell and aesthetic clinic network with 6+ branches across Surabaya, Jakarta, Bandung, and Bali. In 2023, she launched Natural Killer (NK) Cell therapy in Indonesia, described as the first in Asia to offer the treatment at international GSCG/ISSCA-certified standards.

Education

  • Graduate — Universitas Wijaya Kusuma (Surabaya).

Work experience

  • Director — ISSCA Asia Chapter (International Society for Stem Cell Application) — Cellular Institute.
  • Advisory Board member — Cellular Institute.
  • Founder — Indonesia’s GSCG-certified stem cell network.

Clinical focus and techniques

At Cellular Institute, Yanti Khusmiran’s profile places her work within stem cell therapy, regenerative medicine, and regenerative aesthetics. Her clinic activity includes mesenchymal stem cell protocols, NK Cell therapy, and exosome therapy, along with training and standards for cellular immunotherapy delivery.

  • Mesenchymal stem cell protocols for regeneration, anti-aging, immune modulation, and chronic disease management.
  • Natural Killer (NK) Cell therapy (NK cell immunotherapy).
  • Exosome therapy.

Professional societies and certifications

  • International Society for Stem Cell Application (ISSCA) — ISSCA Asia Chapter (Director).
  • GSCG/ISSCA-certified training center — Jakarta (as described).
  • GSCG-certified stem cell network (as described).
  • GSCG/ISSCA-certified standards for NK Cell therapy (as described).

Courses and advanced training

  • Jakarta clinic described as a GSCG/ISSCA-certified training center educating physicians on stem cell protocols, NK Cell therapy, and regenerative medicine standards.

Cellular Institute’s international program supports discovery calls and physician evaluation before regenerative therapy planning. Yanti Khusmiran’s profile emphasizes that advanced cellular immunotherapy and regenerative protocols are delivered through certified standards, including the 2023 NK Cell therapy launch in Indonesia.

Das könnte Sie auch interessieren

Bezahlung und Belohnungen

Sie zahlen nicht für unsere Dienstleistungen

Sie zahlen direkt in der Klinik oder auf deren offizielles Bankkonto.

Sichere Buchung

Einige Kliniken können eine Anzahlung als Teil ihrer Police verlangen.

Flexible Raten

Verteilen Sie Ihre Zahlungen mit Ratenzahlungsoptionen.

Empfehlungsprogramm

Laden Sie Freunde zu Bookimed ein und erhalten Sie Belohnungen.